EconomicKenya·3 Nov 2026
FDA Grants Tentative Approval to Generic HIV Prevention Injection
AI-summarized · Neutrality-checked
The U.S. FDA granted tentative approval to Dr. Reddy’s Laboratories for the first generic version of the HIV prevention injection lenacapavir, a milestone reached just 16 months after the original product's approval. This development was supported by a September 2025 pricing agreement between Dr. Reddy’s, Unitaid, Wits RHI, and the Clinton Health Access…
Loading full story…
Sources and context
Capital FM
Profile pending
Source-level context, not a score for this article. Methodology and evidence · Report outdated information
Know where. Know why.